Senter PD - Search Results

1

Cephalosporin prodrugs of paclitaxel for immunologically specific activation by L-49-sFv-beta-lactamase fusion protein.

Vrudhula VM, Kerr DE, Siemers NO, Dubowchik GM, Senter PD. Vrudhula VM, et al. Among authors: senter pd. Bioorg Med Chem Lett. 2003 Feb 10;13(3):539-42. doi: 10.1016/s0960-894x(02)00935-6. Bioorg Med Chem Lett. 2003. PMID: 12565967

2

Reductively activated disulfide prodrugs of paclitaxel.

Vrudhula VM, MacMaster JF, Li Z, Kerr DE, Senter PD. Vrudhula VM, et al. Among authors: senter pd. Bioorg Med Chem Lett. 2002 Dec 16;12(24):3591-4. doi: 10.1016/s0960-894x(02)00784-9. Bioorg Med Chem Lett. 2002. PMID: 12443783

3

Monoclonal antibody-beta-lactamase conjugates for the activation of a cephalosporin mustard prodrug.

Svensson HP, Kadow JF, Vrudhula VM, Wallace PM, Senter PD. Svensson HP, et al. Among authors: senter pd. Bioconjug Chem. 1992 Mar-Apr;3(2):176-81. doi: 10.1021/bc00014a013. Bioconjug Chem. 1992. PMID: 1515470

4

Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.

Kerr DE, Schreiber GJ, Vrudhula VM, Svensson HP, Hellström I, Hellström KE, Senter PD. Kerr DE, et al. Among authors: senter pd. Cancer Res. 1995 Aug 15;55(16):3558-63. Cancer Res. 1995. PMID: 7627964

5

Cephalosporin derivatives of doxorubicin as prodrugs for activation by monoclonal antibody-beta-lactamase conjugates.

Vrudhula VM, Svensson HP, Senter PD. Vrudhula VM, et al. Among authors: senter pd. J Med Chem. 1995 Apr 14;38(8):1380-5. doi: 10.1021/jm00008a016. J Med Chem. 1995. PMID: 7731023

6

Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-beta-lactamase conjugates.

Vrudhula VM, Svensson HP, Kennedy KA, Senter PD, Wallace PM. Vrudhula VM, et al. Among authors: senter pd. Bioconjug Chem. 1993 Sep-Oct;4(5):334-40. doi: 10.1021/bc00023a005. Bioconjug Chem. 1993. PMID: 8274516

7

Prodrugs of doxorubicin and melphalan and their activation by a monoclonal antibody-penicillin-G amidase conjugate.

Vrudhula VM, Senter PD, Fischer KJ, Wallace PM. Vrudhula VM, et al. Among authors: senter pd. J Med Chem. 1993 Apr 2;36(7):919-23. doi: 10.1021/jm00059a018. J Med Chem. 1993. PMID: 8464046

8

Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation.

Siemers NO, Kerr DE, Yarnold S, Stebbins MR, Vrudhula VM, Hellström I, Hellström KE, Senter PD. Siemers NO, et al. Among authors: senter pd. Bioconjug Chem. 1997 Jul-Aug;8(4):510-9. doi: 10.1021/bc9700751. Bioconjug Chem. 1997. PMID: 9258449

9

Immunologically specific activation of a cephalosporin derivative of mitomycin C by monoclonal antibody beta-lactamase conjugates.

Vrudhula VM, Svensson HP, Senter PD. Vrudhula VM, et al. Among authors: senter pd. J Med Chem. 1997 Aug 15;40(17):2788-92. doi: 10.1021/jm970108y. J Med Chem. 1997. PMID: 9276025

10

Development and activities of a new melphalan prodrug designed for tumor-selective activation.

Kerr DE, Li Z, Siemers NO, Senter PD, Vrudhula VM. Kerr DE, et al. Among authors: senter pd. Bioconjug Chem. 1998 Mar-Apr;9(2):255-9. doi: 10.1021/bc970163l. Bioconjug Chem. 1998. PMID: 9548542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters